Latest filing published 15 Nov 2016 for Aralez Pharmaceuticals Inc., €3,380.
Insider track record
Kenneth B Lee Jr: trading record in brief
Kenneth B Lee Jr discloses dealings in Aralez Pharmaceuticals Inc. to SEC (Form 4). Between 5 February 2016 and 14 November 2016, the trades on record add up to 4 filings.
Every open-market trade on record is a purchase: 2 purchases worth €5,775, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 15 November 2016, the filings show an open-market purchase worth €3,380 in Aralez Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kenneth B Lee Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ CA$4.9513.2% of flowCommon SharesTSXSEDI:2912948Canonical exit: 12 Feb 2017 (T+90)
- 7,986 shares@ CA$3.5877.5% of flowCommon SharesTSXSEDI:2851563
- 1,000 shares@ CA$3.509.3% of flowCommon SharesTSXSEDI:2839432Canonical exit: 11 Aug 2016 (T+90)
- Common SharesTSXSEDI:2787366
4 of 4 declarations
